Abstract
Background
Hemorrhoid disease (HD) affects 10 million people in the US at any given time, and 50% of the US population will develop symptomatic hemorrhoids during their lifetime. Approximately 60% of people with hemorrhoids experience symptoms. Despite its prevalence and impact on quality of life, the existing patient-reported outcome measures of HD have not been validated using standard psychometric methods. The present study thus aimed to develop the Hemorrhoid Disease Symptom Impact Measure™ (HDSIM™) assessment system, a patient-reported measure of HD symptoms and impact for use in HD clinical research.
Methods
On the basis of results from qualitative cognitive interviews, we generated the conceptual model and item pool. A cross-sectional web-based survey (n = 1066) was done, including a randomly selected retest subsample (n = 100) 1–2 weeks later. The survey sample was selected to be evenly distributed across mild, moderate, and severe levels of disease and to be nationally representative of the general United States population in terms of race, gender, and region. Existing disease-specific measures of symptoms and generic measures of quality of life and well-being were compared to the new tool for construct validation.
Results
The HDSIM system includes 38 items representing six conceptual-model-driven subscales, aligning with the conceptual model: Symptoms at Worst, Symptoms at Best, Bowel Health Impact, Life Impact, Mental Health Impact, and Manageability. Psychometric analyses documented that the subscales had excellent internal consistency reliability, cross-sectional construct validity (i.e., convergent and divergent validity, known groups validity), test–retest stability, and longitudinal construct validity (i.e., responsiveness).
Conclusion
The HDSIM system is fit for purpose in hemorrhoid disease clinical trials research. Since measures are validated in an iterative manner over many studies and over time, the present study results should be considered preliminary.
Similar content being viewed by others
Notes
HDSIM™ is a trademark of Cristcot LLC.
The “problematic” item removed from the Bowel Health Impact scale was removed in this series of analyses.
6 life impact, 8 mental health impact, and 5 bowel health/problems.
In our SPSS data set, a response of “Not at all” was coded as “1” and “Very much” was coded as “5,” whereas these same responses were coded as “0” and “4,” respectively in IRTPRO.
Abbreviations
- CFA:
-
Confirmatory factor analysis
- CORECTS:
-
COloRectal Evaluation of Clinical Therapeutics Scale
- CTT:
-
Classical Test Theory
- EFA:
-
Exploratory factor analysis
- ES:
-
Effect size
- HD:
-
Hemorrhoid Disease
- HDSIM:
-
Hemorrhoid Disease Symptom Impact Measure
- HIPAA:
-
Health Insurance Portability and Accountability Act
- IRT:
-
Item Response Theory
- PRO:
-
Patient-reported outcome
- PROMIS:
-
Patient-Reported Outcome Measurement Information System
- QOL:
-
Quality of life
References
Pullen, R. L., Jr. (2022). Hemorrhoidal disease: What nurses need to know. Nursing, 52(5), 19–24.
Luchtefeld, M., & Hemorrhoids, H. R. E. (2016). The ASCRS Textbook of Colon and Rectal Surgery (pp. 183–203). Cham: Springer.
Simmons, S. (1964). Ano-rectal disorders in pregnancy. BJOG: Int J Obstet Gynaecol, 71(6), 960–962.
Riss, S., Weiser, F. A., Schwameis, K., et al. (2012). The prevalence of hemorrhoids in adults. International Journal of Colorectal Disease, 27(2), 215–220.
Johannsson, H. Ö., Graf, W., & Påhlman, L. (2005). Bowel habits in hemorrhoid patients and normal subjects. American Journal of Gastroenterology, 100(2), 401–406.
Lunsford, T. N., Atia, M. A., Kagbo-Kue, S., & Harris, L. A. (2022). A pain in the Butt: Hemorrhoids, fissures, fistulas, and other anorectal syndromes. Gastroenterology Clinics, 51(1), 123–144.
Yang, J. Y., Peery, A. F., Lund, J. L., Pate, V., & Sandler, R. S. (2019). Burden and cost of outpatient hemorrhoids in the United States employer-insured population, 2014. American Journal of Gastroenterology, 114(5), 798.
Sandler, R. S., & Peery, A. F. (2019). Rethinking what we know about hemorrhoids. Clinical Gastroenterology and Hepatology, 17(1), 8–15.
Goligher, J. C. (1980). Surgery of the Anus Rectum and Colon (pp. 924–925). Bailliere Tindall.
Dekker, L., Han-Geurts, I., Grossi, U., Gallo, G., & Veldkamp, R. (2022). Is the Goligher classification a valid tool in clinical practice and research for hemorrhoidal disease? Techniques in Coloproctology, 26(5), 387–392.
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims (US Department of Health and Human Services Food and Drug Administration) (2009).
Kirwan, J. R., De Wit, M., Frank, L., et al. (2017). Emerging guidelines for patient engagement in research. Value in Health., 20(3), 481–486.
Ebrahimi, N., Vohra-Miller, S., & Koren, G. (2011). Anorectal symptom management in pregnancy: Development of a severity scale. Journal of Population Therapeutics and Clinical Pharmacology, 18(1), e99–e105.
Pucher, P., Qurashi, M., Howell, A. M., et al. (2015). Development and validation of a symptom-based severity score for haemorrhoidal disease: The Sodergren score. Colorectal Disease, 17(7), 612–618.
Rørvik, H. D., Styr, K., Ilum, L., et al. (2019). Hemorrhoidal disease symptom score and short health ScaleHD: New tools to evaluate symptoms and health-related quality of life in hemorrhoidal disease. Dis Colon & Rectum, 62(3), 333–342.
Cella, D., Yount, S., Rothrock, N., et al. (2007). The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH roadmap cooperative group during its first two years. Medical Care, 45(5 Suppl 1), S3.
Ryff, C. D. (1989). Happiness is everything, or is it? Explorations on the meaning of psychological well-being. J Personal Soc Psychol, 57, 1069–1081.
Salsman, J. M., Victorson, D., Choi, S. W., et al. (2013). Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QOL) measurement system. Quality of Life Research, 22(9), 2569–2580.
Schwartz, C. E., Stucky, B. D., & Stark, R. B. (2021). Expanding the purview of wellness indicators: Validating a new measure that includes attitudes, behaviors, and perspectives. Health Psychology and Behavioral Medicine, 9(1), 1031–1052.
Kickbusch I, Pelikan JM, Apfel F, Tsouros A. Health Literacy. WHO Regional Office for Europe. 2013.
Schwartz, C. E., Michael, W., Zhang, J., Rapkin, B. D., & Sprangers, M. A. G. (2018). Assessing reserve-building pursuits and person characteristics: Psychometric validation of the DeltaQuest Reserve-Building measure. Quality of Life Research, 27, 423–436. https://doi.org/10.1007/s11136-017-1694-2
Krause, N. M., & Jay, G. M. (1994). What do global self-rated health items measure? Medical Care, 32(9), 930–942.
Wyrwich, K. W., & Tardino, V. M. S. (2006). Understanding global transition assessments. Quality of Life Research, 15(6), 995–1004.
Lt, Hu., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1–55.
Beninato, M., & Ludlow, L. H. (2016). The functional gait assessment in older adults: validation through rasch modeling. Physical Therapy, 96(4), 456–468.
Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bullet, 56(2), 81.
Cohen, J. (1992). A power primer. Psychol Bullet, 112, 155–159.
IBM SPSS Statistics for Windows. Version 28. IBM Corp; 2021.
Muthén LK, Muthén BO. Mplus User's Guide. Eighth ed. Muthén & Muthén; 1998–2022.
IRTPROTM 6.0.6.0. Vector Psychometric Group, LLC; 2023.
Willis, G. B. (2004). Cognitive interviewing: A tool for improving questionnaire design. Sage Publications.
Acknowledgements
We are grateful to Drs. Bruce D. Rapkin and Maria Orlando Edelen for helpful input during data analysis; to Jennifer Davagian and Dr. Mukul Agrawal for input on an earlier draft of the manuscript; to Rare Patient Voice, LLC, and IPSOS-Insight, LLC, for facilitating access to participants for the cognitive interviews and online survey, respectively; and to the participants themselves who provided data for this project.
Funding
This work was funded by Cristcot, LLC.
Author information
Authors and Affiliations
Contributions
CES: designed the research study. CES and KB: analyzed the data. CES: wrote the paper, and KB edited the manuscript. Both authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Data availability
The study data are confidential and thus not able to be shared.
Conflict of interest
Both authors declare that they have no potential conflicts of interest and report no disclosures.
Ethical approval
The protocol was reviewed and approved by the WCG Independent Review Board (WCGIRB #20225513).
Consent to participate
All participants provided informed consent prior to beginning the survey.
Consent for publication
All participants agreed to their data being published in a journal article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Schwartz, C.E., Borowiec, K. Development and validation of the HDSIM™ assessment system: a measure of hemorrhoid disease symptom impact. Qual Life Res (2024). https://doi.org/10.1007/s11136-024-03619-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s11136-024-03619-x